日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial

粪便微生物移植联合免疫疗法治疗非小细胞肺癌和黑色素瘤:FMT-LUMINate II期试验

Duttagupta, Sreya; Messaoudene, Meriem; Hunter, Sebastian; Desilets, Antoine; Jamal, Rahima; Mihalcioiu, Catalin; Belkaid, Wiam; Marcoux, Nicolas; Fidelle, Marine; Suissa, Deborah; Ponce, Mayra; Geiger, Mallia; Malo, Julie; Piccinno, Gianmarco; Punčochář, Michal; Filin, Alysé; Heidrich, Vitor; Rusu, Diana; Mbaye, Babacar; Durand, Sylvere; Ben Aissa, Imen; Puller, Vadim; de Lahondès, Raynald; Blais, Normand; Tehfe, Mustapha; Owen, Scott; Bélanger, Karl; Parvathy, Seema Nair; Shieh, Benjamin; Raphael, Jacques; Lenehan, John; Breadner, Daniel; Rothenstein, Jeffrey; Rozza, Nicholas; Maillou, Jade; Nili, Somayeh; Prifti, Diogjena Katerina; Pinto, Federica; Armanini, Federica; Kim-Schulze, Seunghee; Marron, Thomas U; Kroemer, Guido; Derosa, Lisa; Zitvogel, Laurence; Silverman, Michael; Segata, Nicola; Maleki Vareki, Saman; Routy, Bertrand; Elkrief, Arielle

Targeting PAR-2 with a negative allosteric modulator increases tumor antigen presentation and potentiates anti-PD-1 immunotherapy

使用负变构调节剂靶向PAR-2可增加肿瘤抗原呈递并增强抗PD-1免疫疗法的效果。

Aouad, Samya; Kadiri, Maleck; Allard, David; Skora, Emma; Giraud, Lucie; Fuselier, Camille; Desroys du Roure, Penelope; Mousson, Antoine; Janvier, Aurelie; Baron, Luc; Franchet, Christel; Lecru, Lola; Routy, Bertrand; Malo, Julie; Brugat, Thibaut; Blayo, Anne-Laure; Schann, Stephan; Stagg, John

Multi-Institutional CT Scan-Based Radiomics for Predicting Tumor PD-L1 Expression in Patients with Advanced and Limited Non-Small Cell Lung Cancer

基于多中心CT扫描的放射组学预测晚期和局限期非小细胞肺癌患者肿瘤PD-L1表达

Saber, Ralph; Tonneau, Marion; Salko, Olivier; Liberman, Moishe; Malo, Julie; Elkrief, Arielle; Turcotte, Simon; Bouchard, Nicole; Joubert, Philippe; Kadoury, Samuel; Routy, Bertrand

Improved survival in advanced melanoma patients treated with fecal microbiota transplantation using healthy donor stool in combination with anti-PD1: final results of the MIMic phase 1 trial

采用健康供体粪便进行粪便微生物移植联合抗PD-1治疗,可提高晚期黑色素瘤患者的生存率:MIMic 1期试验的最终结果

Hadi, Danial Khan; Baines, Kelly J; Jabbarizadeh, Behnam; Miller, Wilson H; Jamal, Rahima; Ernst, Scott; Logan, Diane; Belanger, Karl; Esfahani, Khashayar; Elkrief, Arielle; Parvathy, Seema Nair; Silverman, Michael S; Routy, Bertrand; Maleki Vareki, Saman; Lenehan, John Gordon

Computational analysis of whole slide images predicts PD-L1 expression and progression-free survival in immunotherapy-treated non-small cell lung cancer patients

对全切片图像进行计算分析可预测接受免疫治疗的非小细胞肺癌患者的PD-L1表达和无进展生存期

Dia, Abdou Khadir; Kolnohuz, Alona; Yolchuyeva, Sevinj; Tonneau, Marion; Lamaze, Fabien; Orain, Michele; Gagné, Andréanne; Blais, Florence; Coulombe, François; Malo, Julie; Belkaid, Wiam; Elkrief, Arielle; Williamson, Drew; Routy, Bertrand; Joubert, Philippe; Laplante, Mathieu; Bilodeau, Steve; Manem, Venkata Sk

Benzodiazepines interfere with the efficacy of pembrolizumab-based cancer immunotherapy. Results of a nationwide cohort study including over 50,000 participants with advanced lung cancer

苯二氮卓类药物会干扰基于帕博利珠单抗的癌症免疫疗法的疗效。一项纳入超过5万名晚期肺癌患者的全国性队列研究结果证实了这一点。

Montégut, Léa; Rousseau, Adrien; Ungolo, Cinzia; Derosa, Lisa; Fidelle, Marine; Alves Costa Silva, Carolina; Routy, Bertrand; Zitvogel, Laurence; Besse, Benjamin; Pasolli, Edoardo; Kroemer, Guido

Surrogate markers of intestinal dysfunction associated with survival in advanced cancers

与晚期癌症患者生存相关的肠道功能障碍替代标志物

Birebent, Roxanne; Drubay, Damien; Alves Costa Silva, Carolina; Marmorino, Federica; Vitali, Giacomo; Piccinno, Gianmarco; Hurtado, Yoan; Bonato, Adele; Belluomini, Lorenzo; Messaoudene, Meriem; Routy, Bertrand; Fidelle, Marine; Zalcman, Gerard; Mazieres, Julien; Audigier-Valette, Clarisse; Moro-Sibilot, Denis; Goldwasser, François; Scherpereel, Arnaud; Pegliasco, Hervé; Ghiringhelli, François; Reni, Anna; Barlesi, Fabrice; Albiges, Laurence; Planchard, David; Martinez, Stéphanie; Besse, Benjamin; Segata, Nicola; Cremolini, Chiara; Zitvogel, Laurence; Iebba, Valerio; Derosa, Lisa

Coupling culturomics and metagenomics sequencing to characterize the gut microbiome of patients with cancer treated with immune checkpoint inhibitors

结合培养组学和宏基因组测序技术,对接受免疫检查点抑制剂治疗的癌症患者的肠道微生物组进行表征

Diop, Khoudia; Mbaye, Babacar; Nili, Somayeh; Filin, Alysé; Benlaifaoui, Myriam; Malo, Julie; Renaud, Anne Sophie; Belkaid, Wiam; Hunter, Sebastian; Messaoudene, Meriem; Lee, Karla A; Elkrief, Arielle; Routy, Bertrand

Clinical Utility of Liquid Biopsy for the Early Diagnosis of EGFR-Mutant Advanced Lung Cancer Patients in a Real-Life Setting (CLEAR Study)

液体活检在真实世界环境中对 EGFR 突变型晚期肺癌患者早期诊断的临床应用价值(CLEAR 研究)

Samaha, Ramy; El Sayed, Rola; Alameddine, Raafat; Florescu, Marie; Tehfe, Mustapha; Routy, Bertrand; Elkrief, Arielle; Belkaid, Wiam; Desilets, Antoine; Weng, Xiaoduan; Nassabein, Rami; Blanc-Durand, Félix; Kenth, Gurvinder; Kasymjanova, Goulnar; Agulnik, Jason; Blais, Normand

Antibiotic Exposure Does Not Impact Anti-BRAF/Anti-MEK Targeted Therapy Outcome in Patients with Advanced Melanoma

抗生素暴露不影响晚期黑色素瘤患者接受抗BRAF/抗MEK靶向治疗的疗效

Wang, Yu Shi; Wang, Qing Yin; Moise, Alexia Erika; Syed, Hamida Claudia; Malo, Julie; Soberano, Spencer; Belkaid, Wiam; Messaoudene, Meriem; Bélanger, Karl; Desilets, Antoine; Jamal, Rahima; Routy, Bertrand; Elkrief, Arielle